Aterian, Inc. Form 8-K Summary
Business Context and Reporting Period
Aterian, Inc. filed a Form 8-K dated June 10, 2021, reporting a private placement of common stock. The transaction closed on June 15, 2021. The filing concerns a financing event rather than quarterly or annual operating results.
Transaction and Key Financial Metrics
- Issued 2,666,667 shares of common stock at $15.00 per share.
- The filing states that the offering was for up to $40.0 million. The stated share count and price imply approximately $40.0 million of gross proceeds, subject to the filing’s rounding.
- The placement agent received a cash fee equal to 7.0% of gross proceeds, or approximately $2.8 million based on $40.0 million, plus specified legal and other out-of-pocket expenses.
- Estimated proceeds before reimbursed expenses were approximately $37.2 million, based on the stated $40.0 million gross proceeds and 7.0% fee. The filing does not provide a final net-proceeds figure.
- No revenue, profit, cash-flow, margin, debt, liquidity balance, or other operating metrics are provided in this filing.
Material Changes Versus the Prior Comparable Period
- The transaction increased shares outstanding and may result in dilution to existing stockholders; the filing does not provide the pre- or post-transaction share count or dilution percentage.
- The financing provided new capital for working capital, business operations, general corporate purposes, potential acquisitions, investments or licenses, operating expenses, and capital expenditures.
- No comparable-period financial results are presented, so operating changes versus a prior period cannot be assessed from this filing.
Guidance, Outlook, Risks, and Unusual Items
- Aterian agreed to use commercially reasonable efforts to file a resale registration statement for the investors’ shares and to seek effectiveness within 60 days after closing if the SEC does not review it, or within 90 days if the SEC reviews it.
- The registration statement is intended to remain effective until no investor owns any shares, subject to the agreement’s terms.
- Subject to exceptions, Aterian agreed not to enter into or announce certain issuances of common stock or common-stock equivalents for 60 days after the registration statement becomes effective.
- The shares were sold to accredited investors under an exemption from registration under Section 4(a)(2) and/or Rule 506 of Regulation D. The shares were not initially registered and cannot be resold in the United States absent registration or an applicable exemption.
- Management’s stated use of proceeds is broad and includes acquisitions and investments; no specific acquisition or investment was announced.
- The filing identifies risks relating to Aterian’s financial position, market conditions, use of proceeds, resale registration, and other risks disclosed in its SEC filings. No specific contingency or unusual operating item is quantified.
Important Facts for Investors to Verify
- Confirm the final gross and net proceeds, including placement-agent expenses and other transaction costs.
- Confirm the number of common shares outstanding before and after the offering and the resulting dilution.
- Track the filing and effectiveness of the resale registration statement and any restrictions on investor resales.
- Review how the proceeds are ultimately allocated, particularly for acquisitions, investments, or capital expenditures.
- Read the full Securities Purchase Agreement and Placement Agent Agreement filed as Exhibits 10.1 and 10.2, together with Aterian’s periodic SEC filings.